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Abstract
Levels of plasma cyclic AMP, serum immunoreactive insulin (IRI), serum c-peptide immunore-
activity (CPR) and blood sugar (BS) were determined 0, 15, 30, 45 and 60 min after a glucagon
injection (0.01 mg per kg body weight) in normal controls, patients with acute hepatitis and liver
cirrhosis. Plasma cyclic AMP responses to glucagon in liver disease patients varied widely in peak
value, and only in patients with fulminant hepatitis and decompensated liver cirrhosis with poor
prognosis was the response suppressed. The peak response of BS was found significantly later in
liver cirrhosis patients than in normal controls. IRI and CPR responses to glucagon were lower
in acute hepatitis patients than in normal controls and liver cirrhosis patients. IRI levels and their
sum were also lower in acute hepatitis patients, although CPR levels were not significantly differ-
ent. Thus, the ratio of the sum of CPR from 0 to 60 min to that of IRI was significantly higher in
acute hepatitis, indicating impaired pancreatic secretion of insulin to glucagon stimulation as well
as increased uptake of insulin by the liver in acute hepatitis.
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